Immunological Consequences of COVID-19 Vaccination in Patients with Rheumatic Diseases
Overview
Tab Title Description
Study type
InterventionalDescribes the nature of a clinical study. Types include:
- Observational study — observes people and measures outcomes without affecting results.
- Interventional study (clinical trial) — studies new tests, treatments, drugs, surgical procedures or devices.
- Medical records research — uses historical information collected from medical records of large groups of people to study how diseases progress and which treatments and surgeries work best.
Study IDs
Site IRB
- Rochester, Minnesota: 21-000501
NCT ID: NCT04839315
About this study
This research trial will study the immune respone to COVID-19 vaccination in patients with rheumatic diseases.
Participation eligibility
Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.
Inclusion Criteria:
- Rheumatologist confirmed diagnosis of one of the following diagnoses:
- Systemic lupus erythematosus;
- Sjogren syndrome;
- Inflammatory myositis;
- Psoriatic arthritis;
- Osteoarthritis;
- Gout;
- Ankylosing spondylitis;
- IBD-related arthritis.
Exclusion Criteria:
- Active infection or untreated malignancy (other than skin cancer) at enrollment.
- Pregnancy.
Participating Mayo Clinic locations
Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.
| Mayo Clinic Location |
Status |
|
Rochester, Minn.
Mayo Clinic principal investigator Hu Zeng, Ph.D. |
Closed for enrollment |
|
More information
Publications
Publications are currently not available